Updates on REM Sleep Behavior Disorder Management

This chapter focuses on the latest clinical practice guidelines for managing REM Sleep Behavior Disorder (RBD), highlighting safety considerations in patient environments. It discusses pharmacotherapy options, including the cautious use of medications like clonazepam, melatonin, and rivastigmine, while emphasizing the need for personalized approaches based on clinical judgment. Additionally, the chapter addresses the complexities of RBD's association with neurodegenerative disorders and the importance of ongoing patient-provider relationships in treatment and research.